SCHEMBL6239365

SCHEMBL6239365

O=C(O)Cc1ccc(Oc2c(-c3ccccc3)ccc3ccccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.49
GAA P10253 2/20 0.47
ABCC4 O15439 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
PTGS1 P23219 1/20 0.47
HTT P42858 1/20 0.47
THRA P10827 2/20 0.47
THRB P10828 2/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
AKR1B1 P15121 3/20 0.47
NR3C1 P04150 1/20 0.44
PTGER4 P35408 1/20 0.43
NR1H4 Q96RI1 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
SGK1 O00141 1/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189113 0.87 FFAR1 (0.57) SRD5A2AKR1B1
SCHEMBL6237474 0.83 SRD5A2 (0.50) SRD5A2GAAPTGS1AKR1B1NR3C1
SCHEMBL6239925 0.83 SRD5A2 (0.50) SRD5A2GAAABCC4LMNATSHR
SCHEMBL7190482 0.81 ESR1 (0.53) SRD5A2AKR1B1
SCHEMBL7187264 0.80 FFAR1 (0.56) SRD5A2AKR1B1
SCHEMBL7188049 0.80 FFAR1 (0.56) SRD5A2AKR1B1ALDH1A1
SCHEMBL8501340 0.80 ELANE (0.48) LMNAHTTALDH1A1MAPT
SCHEMBL7190740 0.78 FFAR1 (0.53) AKR1B1
SCHEMBL8501058 0.78 ENPP2 (0.39) MAPT
SCHEMBL7183993 0.77 ESR1 (0.59) SRD5A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005009104-A2 BENZOIC AND PHENYL ACETIC ACID DERIVATIVES AS HNF-4 MODULATORS LIGAND PHARMACUETICALS INCORPORATED (US) 2005-02-03 WO claimed
WO-2005009104-A2 BENZOIC AND PHENYL ACETIC ACID DERIVATIVES AS HNF-4 MODULATORS LIGAND PHARMACUETICALS INCORPORATED (US) 2005-02-03 WO disclosed